- Age greater than or equal to 8 years.
- Subjects who are starting treatment with growth hormone (Genotropin) for the first
- Subjects with Prader-Willi syndrome or chronic renal insufficiency.
- Subjects and caregivers who, in the opinion of the investigator are not able to
adequately participate in the study.
- Subjects with chronic systemic disorders, such as diabetes and heart disease.